We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Benchtop System Dispenses Low Volumes with High Precision

By HospiMedica staff writers
Posted on 03 Aug 2006
A complete high-throughput system for low volume, high-precision pipetting can perform a 1536-well plate dispense in less than eight seconds with the complete aspirate/dispense cycle time of 30 seconds.

The 16-channel Nanodrop Express, a fast benchtop system produced by Innovadyne Technologies (Santa Rosa, CA.USA), has a two-plate stage and interchangeable 1 x 16 or 2 x 8 tip heads specialized for reagent dispensing and sample transfer. More...
Based on Nanodrop fluidics, the instrument combines the advantages of non-contact solenoid-based technology (high-precision miniaturized assays) with the robustness and flexibility of traditional liquid handlers.

The flow-regulating solenoids are isolated from the valve-free flow path and are only exposed to de-ionized water. In addition to dramatically improving robustness, i.e., valve life measured in years, the system design enables repetitive, precise, low-volume dispensing of difficult samples like beads, cells, and highly viscous mixtures. Other non-contact liquid handlers use a flow-through design where the reagents pass through the internal path of a solenoid valve, quickly leading to deposits, obstructions, and seal wear. Consequently they work for a limited time, and soon result in costly valve replacement, hard-to-diagnose performance deterioration, and instrument downtime.

Innovadyne also produces a 96-channel platemaker instrument. The instrument's independent 96-tip and eight-tip heads can access plates of various heights in five robot-accessible plate positions. Five hundred nanoliters can be transferred from four 96-well plates to a 384-well plate in less than four minutes. The platemaker offers maximum throughput for high throughput screening (HTS) and genomic applications.

A rapidly growing, privately-held company, Innovadyne Technologies provides robust fluidics solutions to life science researchers for HTS, polymerase chain reaction (PCR), bead dispensing, cell dispensing, protein crystallography, and matrix-assisted laser desorption/ionization (MALDI) plate spotting. The company's isolated-solenoid non-contact dispense technology offers tools that enable increases in throughput, sensitivity, and flexibility for assays, while significantly lowering reagent and other costs.



Related Links:
Innovadyne Technologies

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.